fda warning letters glp-1 compounding october 2025 The has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have FDA issues first cGMP warning

The common stuff, shared by both

They include opioids, inhalers, decongestants, antidepressants, blood pressure drugs and benzodiazepines, like Xanax, used to treat anxiety

stem cell activation (PMID: 20880960) Hair: Stimulated hair follicle stem cells in preclinical research (PMID: 14657002) Human Clinical Data Both peptides lack robust human clinical trial data, though Thymosin Beta-4 (the parent compound of TB-500) has more formal clinical exposure through RegeneRx Biopharmaceuticals' development programs

Pathogenesis Following phagocytosis of foreign material, estrogen treatment, inflammatory conditions, and response to cytokines